Abbvie’s flagship medication Humira is a huge seller in the U.S. and abroad. But as more companies develop their own versions, will Abbvie’s stock crater in the face of tighter competition? I’ll review Abbvie’s balance sheet and fundamentals to let you know whether you should expect the stock to surge — or fall even further in 2020.
The coronavirus is spreading faster than the SARS outbreak in 2003. Markets are falling on fear of a global slowdown. But quick action from world leaders is helping contain the virus. Matt Badiali shares a contrarian strategy for buying great stocks at discounted prices.
Last week, we told you about two low-cost ways to get started on your journey to getting “happy rich” if you’re new to investing. Today, I want to profile two of our premium services. They’re a higher price point — but if you have a little extra cash, the potential reward is even higher!
The coronavirus is spreading fear through global markets. But there is one beaten-down sector that will emerge from the global crisis even stronger. Anthony Planas reveals the No. 1 fund that every investor should add to their portfolio today.
When it comes to investing, it pays to root for the underdog. Charles Mizrahi shows you why unloved and unwanted stocks often possess huge advantages over their competition — and what we can learn from the 3,000-year-old story of David and Goliath.
Research Analyst
Chief Investment Strategist of Money & Markets
Founder, Agora
Director of VIP Services
Founder of Sovereign Man
Early in his career, Shad cut his teeth in the world of music marketing [...]
Financial Analyst
Editor of Strategic Fortunes and three elite services
Editor of Alpha Investor